NCT04137094

Brief Summary

The Centers for Disease Control and Prevention (CDC) recommends that emergency departments (EDs) and other health care facilities conduct HIV and HCV screening to identify and link to care those with undiagnosed infections. Screening for both infections in EDs is preferable due to: the shared overlap of some risk behaviors for HIV and HCV acquisition (e.g., drug use) the relatively high co-occurrence of these infections in some populations the more complex medical needs and worse sequelae for those co-infected, and efficiency. Although some EDs have experimented with dual HIV and HCV screening, best practices on how to conduct screening so as to maximize patient screening uptake have yet to be identified. In this pilot RCT, the investigators will examine the efficacy of the persuasive health communication intervention in convincing adult ED patients who decline rapid HIV/HCV screening to be tested for these infections. Adult ED patients who decline rapid HIV/HCV screening will be randomly assigned to the ED medical staff arm or the HIV/HCV counselor arm. Within each arm, participants further will be randomly assigned to receive the persuasive health communication intervention or to watch a CDC HIV/HCV testing brochures-based video. Following the intervention or control condition, all participants will be offered rapid HIV/HCV testing again.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P50-P75 for not_applicable hiv

Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

October 16, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 23, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

August 20, 2021

Status Verified

November 1, 2020

Enrollment Period

1.2 years

First QC Date

October 16, 2019

Last Update Submit

August 19, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • HIV/HCV testing uptake

    HIV/HCV testing will be remeasured via questionnaire following the intervention

    10 minutes

Study Arms (2)

PHCI with HIV/HCV counselor

EXPERIMENTAL

A persuasive health communication intervention will be performed by a community HIV/HCV test counselor

Behavioral: Persuasive Health Communication Intervention

PHCI with ED Medical Staff

EXPERIMENTAL

A persuasive health communication intervention will be performed by ED medical staff

Behavioral: Persuasive Health Communication Intervention

Interventions

A persuasive health communication intervention will be performed

PHCI with ED Medical StaffPHCI with HIV/HCV counselor

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • English or Spanish speaking

You may not qualify if:

  • HIV positive; HCV positive In an HIV vaccine trial
  • On HIV pre-exposure prophylaxis medication
  • In an HIV or HCV testing study
  • Tested for HIV AND HCV within the past year (per EMR(Electronic Medical Record) review and patient report)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rhode Island Hospital

Providence, Rhode Island, 02907, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeHepatitis C

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesHepatitis, Viral, HumanFlaviviridae InfectionsHepatitisLiver DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Adult ED patients who decline rapid HIV/HCV screening will be randomly assigned to the ED medical staff arm or the HIV/HCV counselor arm. Within each arm, participants further will be randomly assigned to receive the persuasive health communication intervention or watch the CDC HIV/HCV testing brochures-based video.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2019

First Posted

October 23, 2019

Study Start

October 16, 2019

Primary Completion

January 1, 2021

Study Completion

January 1, 2021

Last Updated

August 20, 2021

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations